Cybin Irl Limited
Clinical trials sponsored by Cybin Irl Limited, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Magic Mushroom-Derived drug enters final trial for depression Results expected Mar 2027 (estimated)
-
Magic mushroom compound tested for Long-Term depression relief
Disease control By invitation onlyThis study is a long-term follow-up for people with major depressive disorder who already completed a previous trial with CYB003, a drug similar to psilocybin. It will test how safe and effective CYB003 is over time, with optional extra doses. About 468 participants will be monit…
Phase 3 • Sponsor: Cybin IRL Limited • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New depression pill CYB003 enters final testing phase
Symptom relief OngoingThis study tests an experimental oral drug called CYB003 in 220 adults with major depressive disorder. Participants receive either CYB003 or a placebo alongside their usual treatment. The goal is to see if CYB003 safely reduces depression symptoms better than placebo.
Phase 3 • Sponsor: Cybin IRL Limited • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC